High Risk of Epilepsy After Neonatal Seizures Found
A recent study from Sweden looked at the risk of developing epilepsy after infants experienced seizures shortly after birth.
-
-
Wearable AI Technologies Show Promise for Epilepsy Management
Researchers studied wearable artificial intelligence (AI) technologies designed to help manage epilepsy, which affects around 50 million people worldwide.
-
New Brain Stimulation Method Shows Promise for Neurological Disorders
Researchers studied a new method called transcranial temporal interference stimulation (tTIS) to see how it can help people with various neurological and psychiatric disorders.
-
New Tool Helps Assess Knowledge of Ketogenic Diet Therapy
Researchers studied a new tool called the iKETO-KNOW Questionnaire, which was designed to measure how much adult patients and caregivers know about the ketogenic diet therapy (KDT) for epilepsy.
-
Child Neurologists Need Better Training on Reproductive Health Counseling
This study looked at how child neurologists talk to female patients with epilepsy about reproductive health.
-
Perampanel May Help Control Seizures in Alzheimer’s Patients
Researchers studied the connection between Alzheimer’s disease (AD) and epilepsy, focusing on how these two conditions can affect each other.
-
Comorbidities | Devices & Neuromodulation | Epilepsy Research Summaries | Genetics | New Studies | Safety & First Aid
New Brain Treatment Uses Sound Waves for Neurological Disorders
Researchers studied a technique called transcranial focused ultrasound (tFUS), which is a non-invasive way to stimulate specific areas of the brain using sound waves.
-
Neuron-Specific Enolase May Help Diagnose Brain Disorders
Researchers studied neuron-specific enolase (NSE), an enzyme found in nerve cells, to see how it could help diagnose various neurological and psychiatric disorders.
-
Cenobamate Reduces Focal Seizures in Asian Patients
A study was conducted in China, Japan, and South Korea to evaluate the effectiveness and safety of a medication called cenobamate for adults aged 18 to 70 who have uncontrolled focal seizures.
